Skip to main content
Loading market data...

Compare ETFs

Fees, size, distributions, currency exposure and holdings overlap for two to four funds, side by side.

Two to four symbols separated by commas. ASX funds end in .AX, for example A200.AX.
General information only: nothing on TakeProfits takes into account your objectives, financial situation or needs, and it isn't personal financial advice or a recommendation to buy or sell anything. Consider whether it suits you and get advice from a licensed adviser before acting. Market data may be delayed and comes from third-party sources.

Side by side

Comparison of XPH, VTI
Measure XPHState Street SPDR S&P Pharmaceuticals ETF VTIVanguard Morningstar Total Stock Market ETF
MarketUSNYSE ArcaUSNYSE Arca
IssuerState StreetVanguard
Asset classEquity · USEquity · US
Expense ratio0.35%Expense ratio, filed 24 Oct 20250.03%Expense ratio, filed 28 Apr 2026
Net assets$428.4MAs of 30 Jun 2026 $2.3TAs of 30 Jun 2026
Holdings67As of 30 Jun 2026 3,546As of 30 Jun 2026
12-month distribution yield0.43%1.05%
DistributionsQuarterly$0.2750 in 12 months Quarterly$3.9490 in 12 months
Last price$64.1520 Oct 2026, 20:00 UTC$377.0920 Oct 2026, 20:00 UTC

Holdings overlap

Weighted overlap is the sum, over the securities both funds hold, of the smaller of the two weights. 0% means no shared holdings; 100% means identical portfolios.

Weighted holdings overlap between each pair of funds
FundXPHVTI
XPH Same fund 3.3%at least
VTI 3.3%at least Same fund

XPH and VTI

Weighted overlap
3.3%
At least; up to 3.7% with unstored holdings
Holdings in common
48
65 in XPH, 1,996 in VTI
XPH holdings also in VTI
73.9% by count
80.1% of XPH by weight
VTI holdings also in XPH
2.4% by count
3.3% of VTI by weight

Common holdings matched: 48 by ISIN, 0 by CUSIP and 0 by issuer name. Holdings as of 30 Jun 2026 (XPH) and 30 Jun 2026 (VTI). Only each fund's largest 2,000 positions are stored, so overlap among the smallest positions is not counted.

Largest positions held by both XPH and VTI
HoldingWeight in XPHWeight in VTIOverlapMatched by
Eli Lilly & Co US5324571083 1.61% 1.40% 1.40% ISIN
Johnson & Johnson US4781601046 1.63% 0.84% 0.84% ISIN
Merck & Co Inc US58933Y1055 1.65% 0.44% 0.44% ISIN
Pfizer Inc US7170811035 1.44% 0.19% 0.19% ISIN
Bristol-Myers Squibb Co US1101221083 1.58% 0.16% 0.16% ISIN
Zoetis Inc US98978V1035 1.35% 0.04% 0.04% ISIN
Viatris Inc US92556V1061 1.54% 0.03% 0.03% ISIN
Jazz Pharmaceuticals PLC IE00B4Q5ZN47 1.60% 0.02% 0.02% ISIN
Elanco Animal Health Inc US28414H1032 1.64% 0.02% 0.02% ISIN
Axsome Therapeutics Inc US05464T1043 1.52% 0.01% 0.01% ISIN
How overlap is measured

Each fund's latest public Form N-PORT report lists its positions with the percent of net assets each one makes up. For every security both funds hold, the smaller of its two weights is counted, and those are added up. If fund A holds a stock at 6% and fund B at 4%, that stock adds 4 percentage points.

Securities are matched by ISIN first, then by CUSIP (a US or Canadian ISIN contains the CUSIP), and only as a last resort by issuer name, for non-debt holdings where one fund gives no identifier. Repeated lines of the same security in one fund are added together, and each security is matched once.

Cash funds, repurchase agreements, derivative contracts and short positions are left out because their reported value is not comparable exposure. For funds with more than 2,000 positions only the largest 2,000 are stored, so the result is a lower bound and the possible extra is shown. Reports can be for different month ends, and funds trade between reports.

The count-based shares show how many of one fund's holdings the other also holds, which can be high even when overlap by weight is low. Read more in where the ETF data comes from.

Currency exposure

Weight of holdings denominated in each currency
CurrencyXPHVTI
US dollar (USD) 108.6% 100.5%
IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.

Catalyst evidence

Loading…

Loading evidence…

Supporting sources

    Skip to main content

    All resources and tools

    Market ticker

    Markets

    Research

    Tools

    My investments

    Account

    Region and currency

    Colour theme